Full Name
Ross Andrew Soo
(not current staff)
Variants
Ross, S.
Soo, R.
Soo, R.-A.
Soo, R.A.
Soo, Ross
 
 
 
Email
csiras@nus.edu.sg
 

Publications

Refined By:
File Format:  Adobe PDF
Policy:  Open

Results 1-12 of 12 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
11-Mar-2022A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignanciesHo, Jingshan ; Heong, Valerie; Yong, Wei Peng ; Soo, Ross ; Chee, Cheng Ean ; Wong, Andrea ; Sundar, Raghav; Thian, Yee Liang ; Gopinathan, Anil ; Pang, Mei Yan; Koe, Priscillia; Jeraj, Santhiay Nathan; Soe, Phyu Pyar; Soe, Mu Yar; Tang, Tiffany ; Ng, Matthew CH; Tai, David WM ; Tan, Tira JY ; Xu, Hongmei; Chang, Hua; Landesman, Yosef; Shah, Jatin ; Shacham, Sharon; Lee, Soo Chin ; Tan, Daniel SW ; Goh, Boon Cher ; Tan, David SP 
215-Apr-2023A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological MalignanciesChee, Cheng E ; Ooi, Melissa ; Lee, Soo-Chin ; Sundar, Raghav ; Heong, Valerie; Yong, Wei-Peng ; Ng, Chin Hin ; Wong, Andrea; Lim, Joline SJ ; Tan, David SP ; Soo, Ross ; Tan, Joshua TC; Yang, Song; Thura, Min; Al-Aidaroos, Abdul Qader; Chng, Wee Joo ; Zeng, Qi ; Goh, Boon-Cher 
316-Feb-2023Clinical outcome and prognostic factors for Asian patients in Phase I clinical trialsLoh, Jerold; Wu, Jiaxuan; Chieng, Jenny; Chan, Aurora; Yong, Wei-Peng ; Sundar, Raghav ; Lee, Soo-Chin ; Wong, Andrea; Lim, Joline SJ ; Tan, David SP ; Soo, Ross ; Goh, Boon-Cher ; Tai, Bee-Choo ; Chee, Cheng E 
4Sep-2022Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Asian Patients with Advanced NSCLCHuang, Y; Zhao, JJ; Soon, YY; Kee, A; Tay, SH; Aminkeng, F ; Ang, Y; Wong, A; Goh, BC; Soo, R 
512-May-2023Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung CancerHuang, Yiqing; Zhao, Joseph J; Soon, Yu Yang; Kee, Adrian; Tay, Sen Hee; Aminkeng, Folefac ; Ang, Yvonne; Wong, Alvin SC; Bharwani, Lavina D; Goh, Boon Cher; Soo, Ross A 
61-Jan-2023FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sitesThuya, WL ; Kong, LR ; Syn, NL; Ding, LW ; Cheow, ESH ; Wong, RTX ; Wang, T ; Goh, RMWJ; Song, H ; Jayasinghe, MK; Le, MTN; Hu, JC; Yong, WP ; Lee, SC ; Wong, ALA ; Sethi, G ; Hung, HT ; Ho, PCL ; Thiery, JP ; Sze, SK ; Guo, T; Soo, RA ; Yang, H; Lim, YC ; Wang, L ; Goh, BC 
71-Jun-2022Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patientsHuang, Yiqing; Aminkeng, Folefac ; Wong, Alvin SC; Tay, Sen Hee ; Zhao, Joseph J; Ang, Yvonne; Soo, Ross A ; Goh, Boon Cher 
823-Feb-2022Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin +/- Trastuzumab in Advanced Solid TumorsLee, Matilda Xinwei; Wong, Andrea LA ; Ow, Samuel; Sundar, Raghav ; Tan, David SP ; Soo, Ross A ; Chee, Cheng Ean ; Lim, Joline SJ ; Yong, Wei Peng ; Lim, Siew Eng; Goh, Boon Cher ; Wang, Lingzhi ; Lee, Soo Chin 
91-Nov-2017Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)Nokihara, H; Lu, S; Mok, TSK; Nakagawa, K; Yamamoto, N; Shi, YK; Zhang, L; Soo, RA ; Yang, JC; Sugawara, S; Nishio, M; Takahashi, T; Goto, K; Chang, J; Maemondo, M; Ichinose, Y; Cheng, Y; Lim, WT ; Morita, S; Tamura, T
1030-Sep-2022Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancerHuang, Yiqing; Zhao, Joseph J; Soon, Yu Yang ; Wong, Alvin; Aminkeng, Folefac ; Ang, Yvonne; Asokumaran, Yugarajah; Low, Jia Li; Lee, Matilda; Choo, Joan RE; Chan, Gloria; Kee, Adrian ; Tay, Sen Hee ; Goh, Boon Cher ; Soo, Ross A 
1124-Sep-2021Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine InitiativesJain, Sneha Rajiv; Sim, Wilson; Ng, Cheng Han; Chin, Yip Han; Lim, Wen Hui; Syn, Nicholas L.; Kamal, Nur Haidah Bte Ahmad; Gupta, Mehek; Heong, Valerie; Lee, Xiao Wen; Sapari, Nur Sabrina ; Koh, Xue Qing; Isa, Zul Fazreen Adam ; Ho, Lucius; O’Hara, Caitlin; Ulagapan, Arvindh; Gu, Shi Yu; Shroff, Kashyap; Weng, Rei Chern; Lim, Joey S. Y.; Lim, Diana ; Pang, Brendan ; Ng, Lai Kuan ; Wong, Andrea ; Soo, Ross Andrew ; Yong, Wei Peng ; Chee, Cheng Ean; Lee, Soo-Chin ; Goh, Boon-Cher ; Soong, Richie ; Tan, David S. P. 
121-Jun-2016Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progressionZhang, Wen Cai; Chin, Tan Min ; Yang, Henry; Nga, Min En ; Lunny, Declan Patrick; Lim, Edwin Kok Hao; Sun, Li Li; Pang, Yin Huei ; Leow, Yi Ning; Malusay, Shanneen Rossellini Y; Lim, Priscilla Xin Hui; Lee, Jeravan Zili; Tan, Benedict Jian Wei; Ng, Shyh-Chang ; Lim, Elaine Hsuen ; Lim, Wan Teck ; Tan, Daniel Shao Weng ; Tan, Eng Huat ; Tai, Bee Choo ; Soo, Ross Andrew ; Tam, Wai Leong ; Lim, Bing